Signaling pathways
-
F1842 Anti-PAR2 Antibody (Regeneron patent anti-PAR-2)Summary: Anti-PAR2 Antibody (Regeneron patent anti-PAR-2) -
F1843 Anti-PCLA Antibody (U.Penn. patent anti-PCLA)Summary: Anti-PCLA Antibody (U.Penn. patent anti-PCLA) -
F1844 Anti-PCSK9 Antibody (Merck patent anti-PCSK9)Summary: Anti-PCSK9 Antibody (Merck patent anti-PCSK9) -
F1845 Anti-PCSK9 Antibody (Schering patent anti-PCSK9)Summary: Anti-PCSK9 Antibody (Schering patent anti-PCSK9) -
F1846 Anti-PDCD1/PD-1/CD279 Antibody (UCB patent anti-PD-1)Summary: Anti-PDCD1/PD-1/CD279 Antibody (UCB patent anti-PD-1) -
F1847 Anti-PLA2G1B Antibody (Diaccurate patent anti-sPLA2-GIB)Summary: Anti-PLA2G1B Antibody (Diaccurate patent anti-sPLA2-GIB) -
F1848 Anti-PRAME Antibody (Eureka patent anti-PRAME)Summary: Anti-PRAME Antibody (Eureka patent anti-PRAME) -
F1849 Anti-PROM1/CD133 Antibody (Forerunner patent anti-Prominin-1)Summary: Anti-PROM1/CD133 Antibody (Forerunner patent anti-Prominin-1) -
F1850 Anti-PTGFRN/CD315 Antibody (AG02-ADC)Summary: Anti-PTGFRN/CD315 Antibody (AG02-ADC) -
F1851 Anti-PTPRC/CD45 Antibody (Novartis patent anti-CD45)Summary: Anti-PTPRC/CD45 Antibody (Novartis patent anti-CD45)